The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Molecular pathways that drive diabetic kidney disease
Open accessAbstract
Kidney disease is a major driver of mortality among patients with diabetes and diabetic kidney disease (DKD) is responsible for close to half of all chronic kidney disease cases. DKD usually develops in a genetically susceptible individual as a result of poor metabolic (glycemic) control. Molecular and genetic studies indicate the key role of podocytes and endothelial cells in driving albuminuria and early kidney disease in diabetes. Proximal tubule changes show a strong association with the glomerular filtration rate. Hyperglycemia represents a key cellular stress in the kidney by altering cellular metabolism in endothelial cells and podocytes and by imposing an excess workload requiring energy and oxygen for proximal tubule cells. Changes in metabolism induce early adaptive cellular hypertrophy and reorganization of the actin cytoskeleton. Later, mitochondrial defects contribute to increased oxidative stress and activation of inflammatory pathways, causing progressive kidney function decline and fibrosis. Blockade of the renin-angiotensin system or the sodium-glucose cotransporter is associated with cellular protection and slowing kidney function decline. Newly identified molecular pathways could provide the basis for the development of much-needed novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935 · cited 2×
“The addition of finerenone also led to a reduction of albuminuria in the ARTS-DN study (163) and decreased progression of kidney disease and improved cardiovascular outcomes in the FIDELIO-DKD and FIGARO-DKD studies (161, 164).”
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
The pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · cited 1×
“Mitophagy plays an important role in clearing damaged mitochondria (131).”
BackgroundCardiovascular events with finerenone in kidney disease and type 2 diabetes
Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814 · cited 1×
“The addition of finerenone also led to a reduction of albuminuria in the ARTS-DN study (163) and decreased progression of kidney disease and improved cardiovascular outcomes in the FIDELIO-DKD and FIGARO-DKD studies (161, 164).”
BackgroundPathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Sattar, N., Lee, M. M. Y., Kristensen, S. L., Branch, K. R. H., Del Prato, S., Khurmi, N. S., Lam, C. S. P., Lopes, R. D., McMurray, J. J. V., Pratley, R. E., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00203-5 · Cited by 1,599 · cited 1×
“GLP1 receptor agonists lower albuminuria, but their effect on composite renal outcome is not yet available (168).”
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology
Palikaras, K., Lionaki, E., & Tavernarakis, N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0176-2 · Cited by 1,472
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Self-citationSusztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Self-citationMitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
Familial Clustering of Diabetic Kidney Disease
Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201801 · Cited by 994
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Self-citationGlomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887 · cited 1×
“Low distal tubule sodium chloride delivery registers as low filtration resulting in a vasodilation of the afferent arteriole via the tubuloglomerular feedback mechanism (60).”
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Gerstein, H. C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R. D., Lam, C. S. P., Khurmi, N. S., Heenan, L., Del Prato, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108269 · Cited by 829
Mitochondrial Fission Inhibitors Suppress Endothelin-1-Induced Artery Constriction
Chen, C., Gao, J.-L., Liu, M.-Y., Li, S.-L., Xuan, X.-C., Zhang, X.-Z., Zhang, X.-Y., Wei, Y.-Y., Zhen, C.-L., Jin, J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479536 · Cited by 782
Decoding myofibroblast origins in human kidney fibrosis
Kuppe, C., Ibrahim, M. M., Kranz, J., Zhang, X., Ziegler, S., Perales-Patón, J., Jansen, J., Reimer, K. C., Smith, J. R., Dobie, R., et al. (2021) · Nature · doi:10.1038/s41586-020-2941-1 · Cited by 769 · cited 1×
“Consistent with these observations, single-cell studies on fibrotic human kidney samples indicated that fibroblast activation plays a key role in matrix accumulation (147).”
ResultUS Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States
Johansen, K. L., Chertow, G. M., Foley, R. N., Gilbertson, D. T., Herzog, C. A., Ishani, A., Israni, A. K., Ku, E., Kurella Tamura, M., Li, S., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.01.002 · Cited by 724
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Chung, K. W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B. A., Park, J., Pei, L., Baur, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.003 · Cited by 651
Self-citationHeerspink, H. J. L., Parving, H.-H., Andress, D. L., Bakris, G., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30772-x · Cited by 628
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
Maekawa, H., Inoue, T., Ouchi, H., Jao, T.-M., Inoue, R., Nishi, H., Fujii, R., Ishidate, F., Tanaka, T., Tanaka, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.050 · Cited by 586
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547 · cited 1×
“Recent studies have shown that complete ablation/ inhibition of mTORC1 in podocytes resulted in increased vulnerability and glomerulosclerosis, in contrast to the reported therapeutic health benefits of mTOR inhibitors or just genetic lowering of mTOR level (92).”
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538 · cited 1×
“mTORC1 signaling in podocytes appears to play a central role in the development of DKD (91).”
BackgroundQi, W., Keenan, H. A., Li, Q., Ishikado, A., Kannt, A., Sadowski, T., Yorek, M. A., Wu, I.-H., Lockhart, S., Coppey, L. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4328 · Cited by 479
Wang, W., Wang, Y., Long, J., Wang, J., Haudek, S. B., Overbeek, P., Chang, B. H. J., Schumacker, P. T., & Danesh, F. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.009 · Cited by 476 · cited 1×
“Hyperglycemia has been reported to alter podocyte metabolism by inducing DRP1-mediated mitochondrial fission through ROCK1, leading to detrimental effects in podocytes (105, 106).”
BackgroundSkyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.008 · Cited by 471
Muto, Y., Wilson, P. C., Ledru, N., Wu, H., Dimke, H., Waikar, S. S., & Humphreys, B. D. (2021) · Nature Communications · doi:10.1038/s41467-021-22368-w · Cited by 467
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Meyer, T. W., Bennett, P. H., & Nelson, R. G. (1999) · Diabetologia · doi:10.1007/s001250051447 · Cited by 445
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Self-citationProteinuria in diabetic kidney disease: A mechanistic viewpoint
Jefferson, J. A., Shankland, S. J., & Pichler, R. H. (2008) · Kidney International · doi:10.1038/ki.2008.128 · Cited by 419
Tomita, I., Kume, S., Sugahara, S., Osawa, N., Yamahara, K., Yasuda-Yamahara, M., Takeda, N., Chin-Kanasaki, M., Kaneko, T., Mayoux, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.020 · Cited by 376 · cited 1×
“Some studies suggest that SGLT2is are associated with mild ketosis, and ketone bodies might improve heart and PT function, as they are preferentially metabolized (157, 158).”
BackgroundLong noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy
Long, J., Badal, S. S., Ye, Z., Wang, Y., Ayanga, B. A., Galvan, D. L., Green, N. H., Chang, B. H., Overbeek, P. A., & Danesh, F. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87927 · Cited by 372
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191305 · Cited by 348
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Thomas, M. C., & Cherney, D. Z. I. (2018) · Diabetologia · doi:10.1007/s00125-018-4669-0 · Cited by 348
Miguel, V., Tituaña, J., Herrero, J. I., Herrero, L., Serra, D., Cuevas, P., Barbas, C., Puyol, D. R., Márquez-Expósito, L., Ruiz-Ortega, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140695 · Cited by 344
Self-citationSirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling
Liu, M., Liang, K., Zhen, J., Zhou, M., Wang, X., Wang, Z., Wei, X., Zhang, Y., Sun, Y., Zhou, Z., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00498-4 · Cited by 343
Sirt1 activation protects the mouse renal medulla from oxidative injury
He, W., Wang, Y., Zhang, M.-Z., You, L., Davis, L. S., Fan, H., Yang, H.-C., Fogo, A. B., Zent, R., Harris, R. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41563 · Cited by 317
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
Kikuchi, K., Saigusa, D., Kanemitsu, Y., Matsumoto, Y., Thanai, P., Suzuki, N., Mise, K., Yamaguchi, H., Nakamura, T., Asaji, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09735-4 · Cited by 298
Daehn, I., Casalena, G., Zhang, T., Shi, S., Fenninger, F., Barasch, N., Yu, L., D’Agati, V., Schlondorff, D., Kriz, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71195 · Cited by 294
Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging
Chung, K. W., Lee, E. K., Lee, M. K., Oh, G. T., Yu, B. P., & Chung, H. Y. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070802 · Cited by 288
A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD
Kriz, W., & Lemley, K. V. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030278 · Cited by 286
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Loss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction
Salmon, A. H. J., Ferguson, J. K., Burford, J. L., Gevorgyan, H., Nakano, D., Harper, S. J., Bates, D. O., & Peti-Peterdi, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010017 · Cited by 267
Hyperkalemia risk with finerenone: results from the FIDELIO-DKD Trial
Agarwal, R., Joseph, A., Anker, S. D., Filippatos, G., Rossing, P., Ruilope, L. M., Pitt, B., Kolkhof, P., Scott, C., Lawatscheck, R., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021070942 · Cited by 262 · cited 1×
“Hyperkalemia might be less frequent with finerenone compared with spironolactone, but is one side effect (166).”
BackgroundTofte, N., Lindhardt, M., Adamova, K., Bakker, S. J. L., Beige, J., Beulens, J. W. J., Birkenfeld, A. L., Currie, G., Delles, C., Dimos, I., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30026-7 · Cited by 262
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1251 · Cited by 253
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Declèves, A.-E., Mathew, A. V., Cunard, R., & Sharma, K. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010026 · Cited by 251
Qi, H., Casalena, G., Shi, S., Yu, L., Ebefors, K., Sun, Y., Zhang, W., D’Agati, V., Schlondorff, D., Haraldsson, B., et al. (2017) · Diabetes · doi:10.2337/db16-0695 · Cited by 245
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies
Wu, H., Gonzalez Villalobos, R., Yao, X., Reilly, D., Chen, T., Rankin, M., Myshkin, E., Breyer, M. D., & Humphreys, B. D. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.010 · Cited by 243
Chen, Z., Miao, F., Paterson, A. D., Lachin, J. M., Zhang, L., Schones, D. E., Wu, X., Wang, J., Tompkins, J. D., Genuth, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603712113 · Cited by 238
Masuda, Y., Shimizu, A., Mori, T., Ishiwata, T., Kitamura, H., Ohashi, R., Ishizaki, M., Asano, G., Sugisaki, Y., & Yamanaka, N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61731-2 · Cited by 234
Qiu, C., Huang, S., Park, J., Park, Y., Ko, Y.-A., Seasock, M. J., Bryer, J. S., Xu, X.-X., Song, W.-C., Palmer, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0194-4 · Cited by 233
Self-citationUremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Niewczas, M. A., Sirich, T. L., Mathew, A. V., Skupien, J., Mohney, R. P., Warram, J. H., Smiles, A., Huang, X., Walker, W., Byun, J., et al. (2014) · Kidney International · doi:10.1038/ki.2013.497 · Cited by 225
Tian, Z., Greene, A. S., Pietrusz, J. L., Matus, I. R., & Liang, M. (2008) · Genome Research · doi:10.1101/gr.6587008 · Cited by 223
Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury
Hong, Q., Zhang, L., Das, B., Li, Z., Liu, B., Cai, G., Chen, X., Chuang, P. Y., He, J. C., & Lee, K. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.008 · Cited by 222
Endothelin—Biology and disease
Khimji, A.-K., & Rockey, D. C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.002 · Cited by 222
Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Hershberger, K. A., Martin, A. S., & Hirschey, M. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.5 · Cited by 218
Chagnac, A., Zingerman, B., Rozen-Zvi, B., & Herman-Edelstein, M. (2019) · Nephron · doi:10.1159/000499486 · Cited by 210
Liu, H., Doke, T., Guo, D., Sheng, X., Ma, Z., Park, J., Vy, H. M. T., Nadkarni, G. N., Abedini, A., Miao, Z., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01097-w · Cited by 209
Self-citationMiao, Z., Balzer, M. S., Ma, Z., Liu, H., Wu, J., Shrestha, R., Aranyi, T., Kwan, A., Kondo, A., Pontoglio, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22266-1 · Cited by 208
Self-citationSalem, R. M., Todd, J. N., Sandholm, N., Cole, J. B., Chen, W.-M., Andrews, D., Pezzolesi, M. G., McKeigue, P. M., Hiraki, L. T., Qiu, C., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030218 · Cited by 206
Self-citationBalzer, M. S., Doke, T., Yang, Y.-W., Aldridge, D. L., Hu, H., Mai, H., Mukhi, D., Ma, Z., Shrestha, R., Palmer, M. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31772-9 · Cited by 205
Self-citationDong, F., Zhang, X., Wold, L. E., Ren, Q., Zhang, Z., & Ren, J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706193 · Cited by 203
Effects of dapagliflozin in stage 4 chronic kidney disease
Chertow, G. M., Vart, P., Jongs, N., Toto, R. D., Gorriz, J. L., Hou, F. F., McMurray, J. J. V., Correa-Rotter, R., Rossing, P., Sjöström, C. D., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021020167 · Cited by 201
Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
Li, J., Qu, X., Ricardo, S. D., Bertram, J. F., & Nikolic-Paterson, D. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090923 · Cited by 197
Epigenome-wide association studies identify DNA methylation associated with kidney function
Chu, A. Y., Tin, A., Schlosser, P., Ko, Y.-A., Qiu, C., Yao, C., Joehanes, R., Grams, M. E., Liang, L., Gluck, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01297-7 · Cited by 195
Self-citationA Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., et al. (2018) · Diabetes · doi:10.2337/db17-0914 · Cited by 195
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure
Selvaraj, S., Kelly, D. P., & Margulies, K. B. (2020) · Circulation · doi:10.1161/circulationaha.119.045033 · Cited by 193
Wilson, P. C., Muto, Y., Wu, H., Karihaloo, A., Waikar, S. S., & Humphreys, B. D. (2022) · Nature Communications · doi:10.1038/s41467-022-32972-z · Cited by 193
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Gil, N., Goldberg, R., Neuman, T., Garsen, M., Zcharia, E., Rubinstein, A. M., van Kuppevelt, T., Meirovitz, A., Pisano, C., Li, J.-P., et al. (2012) · Diabetes · doi:10.2337/db11-1024 · Cited by 190
Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies
Ricciardi, C. A., & Gnudi, L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154890 · Cited by 190
Sheng, X., Guan, Y., Ma, Z., Wu, J., Liu, H., Qiu, C., Vitale, S., Miao, Z., Seasock, M. J., Palmer, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00909-9 · Cited by 180
The Diabetes Control and Complications Trial -- Implications for Policy and Practice
Lasker, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291410 · Cited by 177
Brinkkoetter, P. T., Bork, T., Salou, S., Liang, W., Mizi, A., Özel, C., Koehler, S., Hagmann, H. H., Ising, C., Kuczkowski, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.012 · Cited by 175
ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes
Ducasa, G. M., Mitrofanova, A., Mallela, S. K., Liu, X., Molina, J., Sloan, A., Pedigo, C. E., Ge, M., Santos, J. V., Hernandez, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125316 · Cited by 175
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
Dhillon, P., Park, J., Hurtado del Pozo, C., Li, L., Doke, T., Huang, S., Zhao, J., Kang, H. M., Shrestra, R., Balzer, M. S., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.011 · Cited by 174
Self-citationAdiponectin Promotes Functional Recovery after Podocyte Ablation
Rutkowski, J. M., Wang, Z. V., Park, A. S. D., Zhang, J., Zhang, D., Hu, M. C., Moe, O. W., Susztak, K., & Scherer, P. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040414 · Cited by 172
Self-citationThe multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development
Doke, T., & Suszták, K. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.03.012 · Cited by 172
Self-citationPodocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease
Shahzad, K., Fatima, S., Khawaja, H., Elwakiel, A., Gadi, I., Ambreen, S., Zimmermann, S., Mertens, P. R., Biemann, R., & Isermann, B. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.010 · Cited by 172
Legouis, D., Ricksten, S.-E., Faivre, A., Verissimo, T., Gariani, K., Verney, C., Galichon, P., Berchtold, L., Féraille, E., Fernandez, M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0238-1 · Cited by 169
The link between obesity and albuminuria: adiponectin and podocyte dysfunction
Sharma, K. (2009) · Kidney International · doi:10.1038/ki.2009.137 · Cited by 168
Advani, A., Huang, Q., Thai, K., Advani, S. L., White, K., Kelly, D. J., Yuen, D. A., Connelly, K. A., Marsden, P. A., & Gilbert, R. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.044 · Cited by 167
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
Hong, Q., Zhang, L., Fu, J., Verghese, D. A., Chauhan, K., Nadkarni, G. N., Li, Z., Ju, W., Kretzler, M., Cai, G., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060599 · Cited by 164
PGC-1α Protects from Notch-Induced Kidney Fibrosis Development
Han, S. H., Wu, M.-Y., Nam, B. Y., Park, J. T., Yoo, T., Kang, S., Park, J., Chinga, F., Li, S., & Suszták, K. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020130 · Cited by 159
Collino, F., Bussolati, B., Gerbaudo, E., Marozio, L., Pelissetto, S., Benedetto, C., & Camussi, G. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00442.2007 · Cited by 148
Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton
Yuan, H., Takeuchi, E., & Salant, D. J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00290.2001 · Cited by 147
Lattenist, L., Lechner, S. M., Messaoudi, S., Mercier, A. L., Moghrabi, S. E., Prince, S., Bobadilla, N. A., Kolkhof, P., Jaisser, F., & Barrera‐Chimal, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08526 · Cited by 146
GCKD Investigators, Schlosser, P., Li, Y., Sekula, P., Raffler, J., Grundner-Culemann, F., Pietzner, M., Cheng, Y., Wuttke, M., Steinbrenner, I., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0567-8 · Cited by 143
VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells
Féliers, D., Chen, X., Akis, N., Choudhury, G. G., Madaio, M. P., & Kasinath, B. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00575.x · Cited by 141
The Genetic Landscape of Renal Complications in Type 1 Diabetes
Sandholm, N., Zuydam, N. V., Ahlqvist, E., Juliusdottir, T., Deshmukh, H., Rayner, N. W., Camillo, B. D., Forsblom, C. M., Fadista, J., Ziemek, D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020231 · Cited by 141
Oh, J. H., Ha, H., Yu, M. R., & Lee, H. B. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00193.x · Cited by 136
Valproic Acid Attenuates Proteinuria and Kidney Injury
Beneden, K. V., Geers, C., Pauwels, M., Mannaerts, I., Verbeelen, D. L., van Grunsven, L. A., & Branden, C. V. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111196 · Cited by 132
Afshinnia, F., Nair, V., Lin, J., Rajendiran, T. M., Soni, T., Byun, J., Sharma, K., Fort, P. E., Gardner, T. W., Looker, H. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130317 · Cited by 131
Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter
Yang, R., Yu, T., Kou, X., Gao, X., Chen, C., Liu, D., Zhou, Y., & Shi, S. (2018) · Nature Communications · doi:10.1038/s41467-018-04464-6 · Cited by 129
Gilbert, R. E., Huang, Q., Thai, K., Advani, S. L., Lee, K., Yuen, D. A., Connelly, K. A., & Advani, A. (2011) · Kidney International · doi:10.1038/ki.2011.39 · Cited by 127
Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease
Majumder, S., Thieme, K., Batchu, S. N., Alghamdi, T. A., Bowskill, B. B., Kabir, M. G., Liu, Y., Advani, S. L., White, K., Geldenhuys, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95946 · Cited by 126
Metabolic Substrates, Cellular Energy Production, and the Regulation of Proximal Tubular Transport
Mandel, L. J. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.000505 · Cited by 124
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α) in Kidney Disease
Li, S., & Suszták, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.003 · Cited by 123
Serum Metabolite Concentrations and Decreased GFR in the General Population
Goek, O.-N., Döring, A., Gieger, C., Heier, M., Koenig, W., Prehn, C., Römisch-Margl, W., Wang-Sattler, R., Illig, T., Suhre, K., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.01.014 · Cited by 121 · cited 1×
“Can lipid metabolites better predict DKD? Large-scale metabolomic studies of the general population have established an inverse correlation between circulating acylcarnitines and eGFR (47).”
BackgroundSun, Y., Qu, X., Zhang, X., Caruana, G., Bertram, J. F., & Li, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055027 · Cited by 121
Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease
Yoshioka, K., Hirakawa, Y., Kurano, M., Ube, Y., Ono, Y., Kojima, K., Iwama, T., Kano, K., Hasegawa, S., Inoue, T., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.039 · Cited by 121
Bjornstad, P., Cherney, D. Z. I., Snell‐Bergeon, J. K., Pyle, L., Rewers, M., Johnson, R. J., & Maahs, D. M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv121 · Cited by 117
Ebefors, K., Wiener, R. J., Yu, L., Azeloglu, E. U., Yi, Z., Fu, J., Zhang, W., Baron, M. H., He, C., Haraldsson, B. S., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.007 · Cited by 115
Direct Action of Endothelin-1 on Podocytes Promotes Diabetic Glomerulosclerosis
Lenoir, O., Milon, M., Virsolvy, A., Hénique, C., Schmitt, A., Massé, J., Kotelevtsev, Y. V., Yanagisawa, M., Webb, D. J., Richard, S., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020195 · Cited by 114
Kidney Proximal Tubule Lipoapoptosis Is Regulated by Fatty Acid Transporter-2 (FATP2)
Khan, S., Cabral, P., Schilling, W. P., Schmidt, Z. W., Uddin, A. N., Gingras, A., Madhavan, S. M., Garvin, J. L., & Schelling, J. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030314 · Cited by 113
DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes
Chen, Z., Miao, F., Braffett, B. H., Lachin, J. M., Zhang, L., Wu, X., Roshandel, D., Carless, M. A., Li, X. A., Tompkins, J. D., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0231-8 · Cited by 113
The role of interleukin-17A in the pathogenesis of kidney diseases
Cortvrindt, C., Speeckaert, R., Moerman, A., Delanghe, J., & Speeckaert, M. M. (2017) · Pathology · doi:10.1016/j.pathol.2017.01.003 · Cited by 110
Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease
Sheng, X., Qiu, C., Liu, H., Gluck, C. A., Hsu, J. Y., He, J., Hsu, C., Sha, D., Weir, M. R., Isakova, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005905117 · Cited by 108
Mechanical stretch induces podocyte hypertrophy in vitro1
Petermann, A. T., Pippin, J. W., Durvasula, R. V., Pichler, R. H., Hiromura, K., Monkawa, T., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00066.x · Cited by 106
Zhang, L., Zhang, Q., Liu, S., Chen, Y., Li, R., Lin, T., Yu, C., Zhang, H., Huang, Z., Zhao, X., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.010 · Cited by 103
Wu, J., Ma, Z., Raman, A., Beckerman, P., Dhillon, P., Mukhi, D., Palmer, M., Chen, H., Cohen, C. R., Dunn, T. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.004 · Cited by 100
Self-citationDoke, T., Abedini, A., Aldridge, D., Yang, Y.-W., Park, J., Hernandez, C. M., Balzer, M. S., Shrestra, R., Coppock, G. M., Inclan-Rico, J. M., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01200-7 · Cited by 100
Self-citationKo, Y.-A., Yi, H., Qiu, C., Huang, S., Park, J., Ledó, N., Köttgen, A., Li, H., Rader, D. J., Pack, M. A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.004 · Cited by 98
Casalena, G., Yu, L., Gil, R., Rodriguez, S., Sosa, S., Janssen, W. G. M., Azeloglu, E. U., Leventhal, J. S., & Daehn, I. S. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00605-x · Cited by 98
Guan, Y., Liang, X., Ma, Z., Hu, H., Liu, H., Miao, Z., Linkermann, A., Hellwege, J. N., Voight, B. F., & Suszták, K. (2021) · Nature Communications · doi:10.1038/s41467-021-25377-x · Cited by 95
Self-citationGluck, C. A., Qiu, C., Han, S. Y., Palmer, M., Park, J., Ko, Y.-A., Guan, Y., Sheng, X., Hanson, R. L., Huang, J. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10378-8 · Cited by 91
YAP-mediated mechanotransduction determines the podocyte’s response to damage
Rinschen, M. M., Grahammer, F., Hoppe, A.-K., Kohli, P., Hagmann, H., Kretz, O., Bertsch, S., Höhne, M., Göbel, H., Bartram, M. P., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8165 · Cited by 90
Fu, J., Wei, C., Zhang, W., Schlöndorff, D., Wu, J., Cai, M., Wu, H., Baron, M. H., Chuang, P. Y., Liu, Z., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.02.028 · Cited by 89
Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression
Khan, S., Gaivin, R. J., Abramovich, C. M., Boylan, M. O., Calles, J., & Schelling, J. R. (2020) · JCI Insight · doi:10.1172/jci.insight.136845 · Cited by 88
Galvan, D. L., Long, J., Green, N., Chang, B. H., Lin, J. S., Schumacker, P. T., Truong, L. D., Overbeek, P. A., & Danesh, F. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127277 · Cited by 86
Cytosine methylation predicts renal function decline in American Indians
Qiu, C., Hanson, R. L., Fufaa, G. D., Kobes, S., Gluck, C. A., Huang, J. Y., Chen, Y., Raj, D. S., Nelson, R. G., Knowler, W. C., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.036 · Cited by 83
Calcium Regulates Podocyte Actin Dynamics
Greka, A., & Mundel, P. H. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.06.003 · Cited by 80
Li, S., Park, J., Qiu, C., Han, S. H., Palmer, M. B., Arany, Z. P., & Suszták, K. (2017) · JCI Insight · doi:10.1172/jci.insight.92930 · Cited by 78
The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes
Li, S., & Suszták, K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90828 · Cited by 77
Mutter, S., Valo, E., Aittomäki, V., Nybo, K., Raivonen, L., Thorn, L. M., Forsblom, C. M., Sandholm, N., Würtz, P., & Groop, P. (2021) · Diabetologia · doi:10.1007/s00125-021-05584-3 · Cited by 75
Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
Yamout, H., Lazich, I., & Bakris, G. L. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.005 · Cited by 74
Functional methylome analysis of human diabetic kidney disease
Park, J., Guan, Y., Sheng, X., Gluck, C. A., Seasock, M. J., Hakimi, A. A., Qiu, C., Pullman, J. M., Verma, A. K., Li, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128886 · Cited by 74
Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis
Chen, Y., Qi, Y., Lv, M., Song, K., Dai, Y., Huang, Y., Zhang, L., Zhang, C., & Gao, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03199-x · Cited by 73
Cheng, J., Encarnación, M. M. D., Warner, G. M., et al. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2005 · Cited by 69
Østergaard, J. A., Jha, J. C., Sharma, A., Dai, A., Choi, J. S. Y., de Haan, J. B., Cooper, M. E., & Jandeleit-Dahm, K. (2022) · Clinical Science · doi:10.1042/cs20210865 · Cited by 67
Frazier, R., Mehta, R., Cai, X., Lee, J., Napoli, S., Craven, T., Tuazon, J., Safdi, A., Scialla, J., Susztak, K., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2018.09.006 · Cited by 63
Zhang, G., Zhang, J., DeHoog, R. J., Pennathur, S., Anderton, C., Venkatachalam, M. A., Alexandrov, T., Eberlin, L. S., & Sharma, K. (2020) · Metabolomics · doi:10.1007/s11306-020-1637-8 · Cited by 63
The Pathogenic Role of Notch Activation in Podocytes
Niranjan, T., Murea, M., & Suszták, K. (2009) · Nephron Experimental Nephrology · doi:10.1159/000209207 · Cited by 56
Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
Sun, J., Wang, Y., Cui, W., Lou, Y., Sun, G., Zhang, D., & Miao, L. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7242384 · Cited by 56
Wieder, N. W., & Greka, A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3224-1 · Cited by 55
Repair Problems in Podocytes: Wnt, Notch, and Glomerulosclerosis
Kato, H., & Suszták, K. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.06.006 · Cited by 54
NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD
Luo, S., Surapaneni, A., Zheng, Z., Rhee, E. P., Coresh, J., Hung, A. M., Nadkarni, G. N., Yu, B., Boerwinkle, E., Tin, A., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08600520 · Cited by 54
Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy
Hou, B., He, P., Ma, P., Yang, X., Xu, C., Lam, S. M., Shui, G., Yang, X., Zhang, L., Qiang, G., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00359 · Cited by 48
Abedini, A., Levinsohn, J. L., Klötzer, K. A., Dumoulin, B., Ma, Z., Frederick, J., Dhillon, P., Balzer, M. S., Shrestha, R., Liu, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513598 · Cited by 43
Self-citationKim, J., Wilbon, S. S., & Fornoni, A. (2021) · Kidney360 · doi:10.34067/kid.0006152020 · Cited by 40
Quinn, G. Z., Abedini, A., Liu, H., Ma, Z., Cucchiara, A. J., Havasi, A., Hill, J., Palmer, M. B., & Suszták, K. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010044 · Cited by 39
Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03448-z · Cited by 39
Palmer, M. B., Abedini, A., Jackson, C., Blady, S. J., Chatterjee, S., Sullivan, K. M., Townsend, R. R., Brodbeck, J., Almaani, S. J., Srivastava, A., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.01.025 · Cited by 38
Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy
Mukhi, D., Nishad, R., Menon, R. K., & Pasupulati, A. K. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00102 · Cited by 36
Self-citationLi, S. N., Li, W., Wu, R., Yin, R., Sargsyan, D., Raskin, I., & Kong, A. T. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0393-z · Cited by 33
Oxidized phosphatidylcholines are produced in renal ischemia reperfusion injury
Solati, Z., Edel, A. L., Shang, Y., Karmin, O., & Ravandi, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195172 · Cited by 31
Patinha, D., Fasching, A., Pinho, D., Albino‐Teixeira, A., Morato, M., & Palm, F. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00285.2012 · Cited by 30
AMPK mediates regulation of glomerular volume and podocyte survival
Banu, K., Lin, Q., Basgen, J. M., Planoutene, M., Wei, C., Reghuvaran, A. C., Tian, X., Shi, H., Garzon, F., Garzia, A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150004 · Cited by 25
Yao, Y., Wang, J., Yoshida, S., Nada, S., Okada, M., & Inoki, K. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010032 · Cited by 22
Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression
Tin, A., Nadkarni, G. N., Evans, A. M., Winkler, C. A., Böttinger, E. P., Rebholz, C. M., Sarnak, M. J., Inker, L. A., Levey, A. S., Lipkowitz, M. S., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101064 · Cited by 22
A model of mitochondrial O2consumption and ATP generation in rat proximal tubule cells
Edwards, A., Palm, F., & Layton, A. T. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00330.2019 · Cited by 20
Quinn, G. Z., Dhillon, P., & Suszták, K. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.010 · Cited by 19
Self-citationCytosine Methylation Studies in Patients with Diabetic Kidney Disease
Arányi, T., & Suszták, K. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1214-6 · Cited by 17
Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease
Sekula, P., Tin, A., Schultheiß, U. T., Baid‐Agrawal, S., Mohney, R. P., Steinbrenner, I., Yu, B., Luo, S., Boerwinkle, E., Eckardt, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66334-w · Cited by 15
The transcriptomic signature of the aging podocyte
Mukhi, D., & Suszták, K. (2020) · Kidney International · doi:10.1016/j.kint.2020.08.004 · Cited by 14
Self-citation
Cited by
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Self-citationDiabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Insights into the molecular underpinning of type 2 diabetes complications
Singh, A., Bocher, O., & Zeggini, E. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae203 · Cited by 10
Metadata
- Authors
- Mohandes, S., Doke, T., Hu, H., Mukhi, D., Dhillon, P., & Susztak, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2023-02-15
- Volume
- 133
- Issue
- 4
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W4320709875
- Cited by
- 341
- References
- 166
- FWCI
- 56.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.